Samil Jung" /> Lisha Yi " /> Jinsun Kim " /> Dongjun Jeong " /> Taejeong Oh " /> Chang-Hwan Kim " /> Chang-Jin Kim " />
Jin Shin " /> Sungwhan An * " /> and Myeong-Sok Lee *

" /> Samil Jung,Lisha Yi, Jinsun Kim, Dongjun Jeong,Taejeong Oh, Chang-Hwan Kim, Chang-Jin Kim,
Jin Shin, Sungwhan An*, and Myeong-Sok Lee*

" /> Samil Jung,Lisha Yi, Jinsun Kim, Dongjun Jeong,Taejeong Oh, Chang-Hwan Kim, Chang-Jin Kim,
Jin Shin, Sungwhan An*, and Myeong-Sok Lee*

. Mol. Cells 2011;31:405-11. https://doi.org/10.1007/s10059-011-0229-x">
TOP

Research Article

Split Viewer

Mol. Cells 2011; 31(5): 405-411

Published online April 8, 2011

https://doi.org/10.1007/s10059-011-0229-x

© The Korean Society for Molecular and Cellular Biology

The Role of Vimentin as a Methylation Bio-marker for Early Diagnosis of Cervical Cancer

Samil Jung, Lisha Yi, Jinsun Kim, Dongjun Jeong1, Taejeong Oh2, Chang-Hwan Kim1, Chang-Jin Kim1,
Jin Shin3, Sungwhan An2,*, and Myeong-Sok Lee*

Division of Biological Science and Research Center for Women’s Diseases, Sookmyung Women's University, Seoul 140-742, Korea, 1Department of Pathology, College of Medicine, Soonchunhyang University, Cheonan 330-090, Korea, 2Genomictree Inc., Daejeon 305-811, Korea, 3Songdo Technopark, Inchon 406-840, Korea

Correspondence to : *Correspondence: mslee@sookmyung.ac.kr (MSL); sungwhan@genomictree.com (SA)

Received: September 10, 2011; Revised: February 28, 2011; Accepted: March 15, 2011

Abstract

Multiple cytosine guanine dinucleotides (CpG island) are found in the VIM promoter region. The levels of VIM pro-moter methylation and VIM gene expression were investi-gated in 7 cervical cancer cell lines and 50 human tissue samples with a distinctive degree of malignant trans-for-mation. While multiple CpG sites in the VIM promoter were highly methylated in CIN III and invasive carcinoma cells, they were rarely methylated in normal cells. Our result shows that methylation in the VIM promoter appears to start from CIN I and CIN II, relatively early stages of multi-step carcinogenesis. This epigenetic alteration in VIM promoter suggests the availability as a biomarker for the early diagnosis and prevention of cervical cancer. We also show that hypermethylation in the VIM promoter is re-sponsible for transcriptional silencing of the VIM gene in cervical cancer cells. In addition, our result shows that exogenous overexpression of the VIM gene in SiHa cer-vical cancer cells slightly activated cell proliferation and migration as shown in soft agar colony formation and migration assays.

Keywords cervical cancer, epigenetic gene regulation, methylation biomarker, VIM

Article

Research Article

Mol. Cells 2011; 31(5): 405-411

Published online May 31, 2011 https://doi.org/10.1007/s10059-011-0229-x

Copyright © The Korean Society for Molecular and Cellular Biology.

The Role of Vimentin as a Methylation Bio-marker for Early Diagnosis of Cervical Cancer

Samil Jung, Lisha Yi, Jinsun Kim, Dongjun Jeong1, Taejeong Oh2, Chang-Hwan Kim1, Chang-Jin Kim1,
Jin Shin3, Sungwhan An2,*, and Myeong-Sok Lee*

Division of Biological Science and Research Center for Women’s Diseases, Sookmyung Women's University, Seoul 140-742, Korea, 1Department of Pathology, College of Medicine, Soonchunhyang University, Cheonan 330-090, Korea, 2Genomictree Inc., Daejeon 305-811, Korea, 3Songdo Technopark, Inchon 406-840, Korea

Correspondence to:*Correspondence: mslee@sookmyung.ac.kr (MSL); sungwhan@genomictree.com (SA)

Received: September 10, 2011; Revised: February 28, 2011; Accepted: March 15, 2011

Abstract

Multiple cytosine guanine dinucleotides (CpG island) are found in the VIM promoter region. The levels of VIM pro-moter methylation and VIM gene expression were investi-gated in 7 cervical cancer cell lines and 50 human tissue samples with a distinctive degree of malignant trans-for-mation. While multiple CpG sites in the VIM promoter were highly methylated in CIN III and invasive carcinoma cells, they were rarely methylated in normal cells. Our result shows that methylation in the VIM promoter appears to start from CIN I and CIN II, relatively early stages of multi-step carcinogenesis. This epigenetic alteration in VIM promoter suggests the availability as a biomarker for the early diagnosis and prevention of cervical cancer. We also show that hypermethylation in the VIM promoter is re-sponsible for transcriptional silencing of the VIM gene in cervical cancer cells. In addition, our result shows that exogenous overexpression of the VIM gene in SiHa cer-vical cancer cells slightly activated cell proliferation and migration as shown in soft agar colony formation and migration assays.

Keywords: cervical cancer, epigenetic gene regulation, methylation biomarker, VIM

Mol. Cells
Sep 30, 2023 Vol.46 No.9, pp. 527~572
COVER PICTURE
Chronic obstructive pulmonary disease (COPD) is marked by airspace enlargement (emphysema) and small airway fibrosis, leading to airflow obstruction and eventual respiratory failure. Shown is a microphotograph of hematoxylin and eosin (H&E)-stained histological sections of the enlarged alveoli as an indicator of emphysema. Piao et al. (pp. 558-572) demonstrate that recombinant human hyaluronan and proteoglycan link protein 1 (rhHAPLN1) significantly reduces the extended airspaces of the emphysematous alveoli by increasing the levels of TGF-β receptor I and SIRT1/6, as a previously unrecognized mechanism in human alveolar epithelial cells, and consequently mitigates COPD.

Share this article on

  • line

Related articles in Mol. Cells

Molecules and Cells

eISSN 0219-1032
qr-code Download